HSA detected theophylline in the named cosmetic. The recall covers all batches supplied in Singapore.
Why it matters
Retail and wholesale suppliers are instructed to stop supply and return remaining stock to the local company.
What we don't know
The notice gives no concentration or exposure estimate. This is not a consumer-level recall or a finding about other NU SKIN products.
Dates and identification
The recall began September 17, 2026; HSA published its notice September 18. Product identifier: CCPN2106638. The local company is NU SKIN ENTERPRISES SINGAPORE PTE LTD.
HSA lists Class 2 and retail-level action following product-quality surveillance testing. Its supplier instructions do not establish a consumer refund programme.
Keep the finding in scope
Readers with the product can consult the linked notice or ask the local company for clarification. An ingredient detection alone does not quantify an individual's risk.
Grade A describes the documented action, not efficacy. This source is a regulator notice, not a sponsored product trial. Checked September 18, 2026.
Open the source file
These links support the claims above. Source dates, disclosures and limits are documented in the article and source list.